267 related articles for article (PubMed ID: 8240409)
1. Inhibition of the human leukocyte endopeptidases elastase and cathepsin G and of porcine pancreatic elastase by N-oleoyl derivatives of heparin.
Baici A; Diczházi C; Neszmélyi A; Móczár E; Hornebeck W
Biochem Pharmacol; 1993 Nov; 46(9):1545-9. PubMed ID: 8240409
[TBL] [Abstract][Full Text] [Related]
2. Novel anthraquinone inhibitors of human leukocyte elastase and cathepsin G.
Zembower DE; Kam CM; Powers JC; Zalkow LH
J Med Chem; 1992 May; 35(9):1597-605. PubMed ID: 1578486
[TBL] [Abstract][Full Text] [Related]
3. A lipophilic heparin derivative protects elastin against degradation by leucocyte elastase.
Moczar E; Hornebeck W
Int J Biol Macromol; 1991 Aug; 13(4):261-2. PubMed ID: 1777434
[TBL] [Abstract][Full Text] [Related]
4. Stereoselective synthesis of peptidyl trifluoromethyl alcohols and ketones: inhibitory potency against human leucocyte elastase, cathepsin G, porcine pancreatic elastase and HIV-1 protease.
Amour A; Reboud-Ravaux M; de Rosny E; Abouabdellah A; Bégue JP; Bonnet-Delpon D; Le Gall M
J Pharm Pharmacol; 1998 Jun; 50(6):593-600. PubMed ID: 9680068
[TBL] [Abstract][Full Text] [Related]
5. Heparin-like dextran derivatives as well as glycosaminoglycans inhibit the enzymatic activity of human cathepsin G.
Ledoux D; Merciris D; Barritault D; Caruelle JP
FEBS Lett; 2003 Feb; 537(1-3):23-9. PubMed ID: 12606025
[TBL] [Abstract][Full Text] [Related]
6. Fatty acid peptide derivatives as model compounds to protect elastin against degradation by elastases.
Hornebeck W; Moczar E; Szecsi J; Robert L
Biochem Pharmacol; 1985 Sep; 34(18):3315-21. PubMed ID: 3849969
[TBL] [Abstract][Full Text] [Related]
7. Effect of sodium oleate on the hydrolysis of human plasma fibronectin by proteinases.
Stanislawski L; Hornebeck W
Biochem Int; 1988 Apr; 16(4):661-70. PubMed ID: 3291875
[TBL] [Abstract][Full Text] [Related]
8. A new class of heterocyclic serine protease inhibitors. Inhibition of human leukocyte elastase, porcine pancreatic elastase, cathepsin G, and bovine chymotrypsin A alpha with substituted benzoxazinones, quinazolines, and anthranilates.
Teshima T; Griffin JC; Powers JC
J Biol Chem; 1982 May; 257(9):5085-91. PubMed ID: 7040392
[TBL] [Abstract][Full Text] [Related]
9. Amino acids and peptides. XXX. Synthesis of eglin c (41-49) and eglin c (60-63) and examination of their inhibitory activity towards human leukocyte elastase, cathepsin G, porcine pancreatic elastase and alpha-chymotrypsin.
Tsuboi S; Takeda M; Okada Y; Nagamatsu Y; Yamamoto J
Chem Pharm Bull (Tokyo); 1991 Jan; 39(1):184-6. PubMed ID: 2049802
[TBL] [Abstract][Full Text] [Related]
10. Mechanism-based inhibition of human leukocyte elastase and cathepsin G by substituted dihydrouracils.
Groutas WC; Huang H; Epp JB; Venkataraman R; McClenahan JJ; Tagusagawa F
Biochim Biophys Acta; 1994 Nov; 1227(3):130-6. PubMed ID: 7986820
[TBL] [Abstract][Full Text] [Related]
11. Interaction of the human leukocyte proteinases elastase and cathepsin G with gold, silver and copper compounds.
Baici A; Camus A; Marsich N
Biochem Pharmacol; 1984 Jun; 33(12):1859-65. PubMed ID: 6428416
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of human leukocyte elastase, cathepsin G, chymotrypsin A alpha, and porcine pancreatic elastase with substituted isobenzofuranones and benzopyrandiones.
Hemmi K; Harper JW; Powers JC
Biochemistry; 1985 Apr; 24(8):1841-8. PubMed ID: 3848330
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of neutrophil cathepsin G by oxidized mucus proteinase inhibitor. Effect of heparin.
Boudier C; Cadène M; Bieth JG
Biochemistry; 1999 Jun; 38(26):8451-7. PubMed ID: 10387091
[TBL] [Abstract][Full Text] [Related]
14. Specificity and reactivity of human leukocyte elastase, porcine pancreatic elastase, human granulocyte cathepsin G, and bovine pancreatic chymotrypsin with arylsulfonyl fluorides. Discovery of a new series of potent and specific irreversible elastase inhibitors.
Yoshimura T; Barker LN; Powers JC
J Biol Chem; 1982 May; 257(9):5077-84. PubMed ID: 6917853
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of leucocyte elastase by heparin and its derivatives.
Redini F; Tixier JM; Petitou M; Choay J; Robert L; Hornebeck W
Biochem J; 1988 Jun; 252(2):515-9. PubMed ID: 3415672
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of the elastolytic activity of leukocyte elastase by leukocyte cathepsin G.
Boudier C; Holle C; Bieth JG
J Biol Chem; 1981 Oct; 256(20):10256-8. PubMed ID: 6912862
[TBL] [Abstract][Full Text] [Related]
17. Heparin accelerates the inhibition of cathepsin G by mucus proteinase inhibitor: potent effect of O-butyrylated heparin.
Ermolieff J; Duranton J; Petitou M; Bieth JG
Biochem J; 1998 Mar; 330 ( Pt 3)(Pt 3):1369-74. PubMed ID: 9494108
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of peptide fragments related to eglin c and examination of their inhibitory effect on human leukocyte elastase, cathepsin G and alpha-chymotrypsin.
Okada Y; Tsuboi S; Tsuda Y; Nakabayashi K; Nagamatsu Y; Yamamoto J
Biochem Biophys Res Commun; 1989 May; 161(1):272-5. PubMed ID: 2730658
[TBL] [Abstract][Full Text] [Related]
19. Novel potential mechanism-based inhibitors of human leukocyte elastase and cathepsin G: derivatives of isothiazolidin-3-one.
Groutas WC; Chong LS; Venkataraman R
Biochem Biophys Res Commun; 1993 Dec; 197(2):730-9. PubMed ID: 8267609
[TBL] [Abstract][Full Text] [Related]
20. Inhibition by recombinant SLPI and half-SLPI (Asn55-Ala107) of elastase and cathepsin G activities: consequence for neutrophil-platelet cooperation.
Renesto P; Balloy V; Kamimura T; Masuda K; Imaizumi A; Chignard M
Br J Pharmacol; 1993 Apr; 108(4):1100-6. PubMed ID: 8097952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
